Skip to content

The Effect of PRP on Ovarian Function and ICSI Success

Evaluation of the Effect of Platelet-Rich Plasma (PRP) on Ovarian Function and ICSI Success in Women with Diminished Ovarian Reserve (DOR)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241127063873N2
Enrollment
300
Registered
2025-08-31
Start date
2025-08-23
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian dysfunction. Ovarian dysfunction

Interventions

Intervention 1: Intervention Group (PRP Group): Receives a single session of intraovarian injection of autologous Platelet-Rich Plasma (PRP) using the Royagen Kit:- Substance Name: Autologous Platelet

Sponsors

Avicenna research institute
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 39 Years

Inclusion criteria

Inclusion criteria: 1. Women aged 20-39 years Diagnosed with diminished ovarian reserve (low AMH and low AFC) Undergoing ICSI

Exclusion criteria

Exclusion criteria: Women with severe uterine abnormalities. Presence of systemic diseases affecting ovarian function. Refusal to participate in follow-up sessions.

Design outcomes

Secondary

MeasureTime frame
Blood FSH hormone level. Timepoint: Before and after the intervention. Method of measurement: Blood FSH measurement kit.;Embryo quality. Timepoint: after treatment. Method of measurement: observation with a microscope.

Primary

MeasureTime frame
Antral fullicular count. Timepoint: Before and after inteventaion. Method of measurement: Ultrasound.;Anti mullerian hormon. Timepoint: Before and after intervention. Method of measurement: Special kit for checking hormones in blood.;Number of mature oocytes. Timepoint: Before and after intervention. Method of measurement: microscope.;Pregnancy. Timepoint: After treatment. Method of measurement: Beta HCG hormone in the blood.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Soheila Arefi

Avicenna Research Institute

Soheilaarefi@yahoo.com+98 21 2351 9630

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026